Navigation Links
No small measure: Origins of nanorod diameter discovered
Date:3/19/2009

Troy, N.Y. A new study answers a key question at the very heart of nanotechnology: Why are nanorods so small?

Researchers at Rensselaer Polytechnic Institute have discovered the origins of nanorod diameter, demonstrating that the competition and collaboration among various mechanisms of atomic transport hold the key to nanorod size. The researchers say it is the first study to identify the fundamental reasons why nearly all nanorods have a diameter on the order of 100 nanometers.

"Scientists have been fabricating nanorods for decades, but no one has ever answered the question, 'Why is that possible?'" said Hanchen Huang, professor in Rensselaer's Department of Mechanical, Aerospace, and Nuclear Engineering, who led the study. "We have used computer modeling to identify, for the first time, the fundamental reasons behind nanorod diameter. With this new understanding, we should be able to better control nanorods, and therefore design better devices."

Results of the study, titled "A characteristic length scale of nanorods diameter during growth," were recently published in the journal Physical Review Letters.

When fabricating nanorods, atoms are released at an oblique angle onto a surface, and the atoms accumulate and grow into nanorods about 100 nanometers in diameter. A nanometer is one billionth of a meter in length.

The accumulating atoms form small layers. After being deposited onto a layer, it takes varying amounts of energy for atoms to travel or "step" downward to a lower layer, depending on the step height. In a previous study, Huang and colleagues calculated and identified these precise energy requirements. As a result, the researchers discovered the fundamental reason nanorods grow tall: as atoms are unable to step down to the next lowest layer, they begin to stack up and grow higher.

It is the cooperation and competition of atoms in this process of multi-layer diffusion that accounts for
'/>"/>

Contact: Michael Mullaney
mullam@rpi.edu
518-276-6161
Rensselaer Polytechnic Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
5. New technique producing small things in large quantities
6. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
7. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
8. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
9. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
10. Government Expands Trial With IMVAMUNE(R) Smallpox Vaccine in Persons With Atopic Dermatitis/Eczema
11. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email: